EUVIMEDEUVIMED entdecken
Crossref

In vitro cytogenotoxicity of novel tetrazole-based Schiff bases and their platinum (II) complexes: a detailed analysis using chromosomal aberration, micronucleus, and comet assays

Fatma Okus, Deniz Yuzbasioglu, Gonca Cakmak, Hasan Berk Demirel iD, Rumeysa Cetin Turker, Fatma Unal

Mutagenesis · 2026

DOI: 10.1093/mutage/geag019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mutagenesis, 2026. Verfasst von Fatma Okus und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gazi University, Graduate School of Natural and Applied Sciences, Department of Biology, Teknikokullar, Ankara 06500, Türkiye. Hauptthemen laut MEDLINE: Tetrazoles, Chromosome Aberrations, Organoplatinum Compounds. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Scientific and Technological Research Council of Turkey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previously, tetrazole-based Schiff base ligands (TBSL) and their Pt(II) complexes were synthesized and evaluated for cytotoxic activity. The results revealed that low cytotoxicity for the ligands and moderate effects for the Pt(II) complexes compared to cisplatin. Given these promising findings, the genotoxic potential of the Pt(II) complexes was further investigated. Genotoxicity was assessed using in vitro chromosomal aberration, micronucleus, and comet assays. The TBSL exhibited low genotoxicity, whereas the Pt(II) complexes induced higher genotoxic effects; however, these effects were lower than those observed for cisplatin. The low cytotoxic and genotoxic profiles of TBSL support their consideration for further pharmaceutical evaluation. In addition, the genotoxicity findings suggest that the Pt(II) complexes merit further investigation in the context of antitumor drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TetrazolesChromosome AberrationsOrganoplatinum CompoundsSchiff BasesComet AssayMicronucleus TestsAnimalsHumansAntineoplastic AgentsCisplatinPlatinumDNA Damage

Stichwörter der Autor:innen

Schiff basechromosomal aberrationcomet assaymicronucleusplatinum complextetrazole

Substanzen

TetrazolesSchiff BasesAntineoplastic AgentsCisplatinPlatinumOrganoplatinum Compounds

Autor:innen und Institutionen

  • Gazi University, Graduate School of Natural and Applied Sciences, Department of Biology, Teknikokullar, Ankara 06500, Türkiye.
  • Gazi University, Faculty of Science, Department of Biology, Teknikokullar, Ankara 06500, Türkiye.
  • Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Yenimahalle, Ankara 06330, Türkiye.
  • Department of Toxicology, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, Afyonkarahisar 03218, Türkiye.

ORCID-Profile: Hasan Berk Demirel

Förderung

  • Scientific and Technological Research Council of Turkey

Zitieren

APA

Okus, F., Yuzbasioglu, D., Cakmak, G., Demirel, H. B., Turker, R. C., & Unal, F. (2026). In vitro cytogenotoxicity of novel tetrazole-based Schiff bases and their platinum (II) complexes: a detailed analysis using chromosomal aberration, micronucleus, and comet assays. Mutagenesis. https://doi.org/10.1093/mutage/geag019

Vancouver

Okus F, Yuzbasioglu D, Cakmak G, Demirel HB, Turker RC, Unal F. In vitro cytogenotoxicity of novel tetrazole-based Schiff bases and their platinum (II) complexes: a detailed analysis using chromosomal aberration, micronucleus, and comet assays. Mutagenesis. 2026. doi:10.1093/mutage/geag019

BibTeX
@article{Okus2026,
  author = {Okus, Fatma and Yuzbasioglu, Deniz and Cakmak, Gonca and Demirel, Hasan Berk and Turker, Rumeysa Cetin and Unal, Fatma},
  title = {In vitro cytogenotoxicity of novel tetrazole-based Schiff bases and their platinum (II) complexes: a detailed analysis using chromosomal aberration, micronucleus, and comet assays},
  journal = {Mutagenesis},
  year = {2026},
  doi = {10.1093/mutage/geag019}
}
Kostenlos starten →